January 26th, 2007
Rate of Tamoxifen Discontinuation, Rising
Tamoxifen is a selective estrogen receptor modulator that inhibits the stimulatory effect that estrogen has on the development of specific types of breast cancer.
An estimated over 40,000 recurrences of breast cancer are prevented each year worldwide, thanks to this wonder drug.
It should be taken note that the optimal duration of tamoxifen therapy is five years […]
Recent Comments